Patent 7846954 was granted and assigned to Vertex Pharmaceuticals on December, 2010 by the United States Patent and Trademark Office.
The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.